2020
DOI: 10.3923/pjbs.2020.231.239
|View full text |Cite
|
Sign up to set email alerts
|

Class 1 Integrons in Clinical Multi Drug Resistance E. coli, Sana’a Hospitals, Yemen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(11 citation statements)
references
References 32 publications
3
8
0
Order By: Relevance
“…Akya et al in Iran found that the highest rate of resistance was noticed for ceftriaxone, cefotaxime, and cotrimoxazole [23] which agrees with a previous study in Iran [24]. A higher percentage of MDR (87.9%) among E. coli isolates was reported by Al-Hammadi and colleagues in Yemen [25].…”
Section: Discussionsupporting
confidence: 79%
See 2 more Smart Citations
“…Akya et al in Iran found that the highest rate of resistance was noticed for ceftriaxone, cefotaxime, and cotrimoxazole [23] which agrees with a previous study in Iran [24]. A higher percentage of MDR (87.9%) among E. coli isolates was reported by Al-Hammadi and colleagues in Yemen [25].…”
Section: Discussionsupporting
confidence: 79%
“…A study conducted in Sudan by Ibrahim et al reported that the percentage of class 1 integrons was 40.6% and the MDR E. coli isolates carrying this class of integrons showed high level resistance to trimethoprim-sulfamethoxazole (98.1%), tetracycline (88.9%), ciprofloxacin (70.4%), amoxicillin-clavulanic acid (66.7%), ceftazidime (46.3 %) and chloramphenicol (29.6%) [30]. Al-Hammadi et al showed that the presence of class 1 integron was observed to be significantly higher in ciprofloxacin (p=0.0002), amoxicillinclavulanic acid (p=0.003), aztreonam (p=0.006), cefepime (p=0.01), cefotaxime (p=0.0003), ceftazidime (p=0.002), ceftriaxone (p = 0.03), norfloxacin (p=0.0002) and trimethoprimsulfamethoxazole (p<0.0001) [25].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The high level of AMR in Yemen perceived by participants indicates awareness among physicians and pharmacists, considered frontline health workers, in this survey and is corroborated by the earlier mentioned studies reporting laboratory investigations. [24][25][26][27][28][29][30] In Yemen, IDPs may not necessarily be distinguished from the non-displaced. Since 2020, displacement has been more marked among four, out of a total of 22 governates (Marib, Al Hudaydah, Al Dhale'e, Taizz, and Al Jawf)mostly in the northwith the greater proportion moving in with relatives or other non-family hosts, rather than into any settlement camps.…”
Section: Amr Prevalence: Perception and Solutionsmentioning
confidence: 99%
“…22,23 Several studies already suggest a high AMR burden. [24][25][26][27][28][29][30] In 2018, for example, among patients admitted to the Médecins Sans Frontiers (MSF) hospital in Aden, more than 60% had a drug resistant infection. 31 These conditions coincide with the current COVID-19 pandemic to further exacerbate the problem.…”
Section: Introductionmentioning
confidence: 99%